LU85331A1 - Nouvelle association medicamenteuse pour le traitement de l'hypertension - Google Patents

Nouvelle association medicamenteuse pour le traitement de l'hypertension Download PDF

Info

Publication number
LU85331A1
LU85331A1 LU85331A LU85331A LU85331A1 LU 85331 A1 LU85331 A1 LU 85331A1 LU 85331 A LU85331 A LU 85331A LU 85331 A LU85331 A LU 85331A LU 85331 A1 LU85331 A1 LU 85331A1
Authority
LU
Luxembourg
Prior art keywords
compound
pharmaceutically acceptable
composition according
dergocrine
component
Prior art date
Application number
LU85331A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU85331A1 publication Critical patent/LU85331A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
LU85331A 1983-04-22 1984-04-20 Nouvelle association medicamenteuse pour le traitement de l'hypertension LU85331A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3314607 1983-04-22
DE3314607 1983-04-22

Publications (1)

Publication Number Publication Date
LU85331A1 true LU85331A1 (fr) 1984-11-28

Family

ID=6197070

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85331A LU85331A1 (fr) 1983-04-22 1984-04-20 Nouvelle association medicamenteuse pour le traitement de l'hypertension

Country Status (27)

Country Link
US (2) US4617306A (no)
JP (1) JPS59205318A (no)
AT (1) AT393625B (no)
AU (1) AU571218B2 (no)
BE (1) BE899434A (no)
CA (1) CA1218932A (no)
CH (1) CH658992A5 (no)
CY (1) CY1499A (no)
DD (1) DD217712A5 (no)
DK (1) DK165965C (no)
FR (1) FR2544614B1 (no)
GB (1) GB2138678B (no)
GR (1) GR81973B (no)
HK (1) HK100289A (no)
HU (1) HU192050B (no)
IE (1) IE57468B1 (no)
IL (1) IL71601A (no)
IT (1) IT1199114B (no)
LU (1) LU85331A1 (no)
MY (1) MY100397A (no)
NL (1) NL188891C (no)
NZ (1) NZ207917A (no)
PH (1) PH20922A (no)
PT (1) PT78455B (no)
SE (1) SE465751B (no)
SG (1) SG53889G (no)
ZA (1) ZA842993B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3580384D1 (de) * 1984-04-09 1990-12-13 Toyo Boseki Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
ES2306646T3 (es) * 1999-02-09 2008-11-16 Pfizer Products Inc. Composiciones de farmacos basicos con biodisponibilidad incrementada.
US6209563B1 (en) 2000-01-07 2001-04-03 Saturn Electronics & Engineering, Inc. Solenoid control valve
US6321767B1 (en) 2000-01-10 2001-11-27 Saturn Electronics & Engineering, Inc. High flow solenoid control valve
US6581634B2 (en) 2000-01-10 2003-06-24 Saturn Electronics & Engineering, Inc. Solenoid control valve with particle gettering magnet
US20090166274A1 (en) * 2007-05-24 2009-07-02 Eaton Corporation Engine valve with a combined engine oil filter and valve actuator solenoid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5468M (no) * 1966-06-24 1967-10-16
US3567828A (en) * 1967-08-17 1971-03-02 Sandoz Ltd Organic compounds
SE426782B (sv) * 1975-05-31 1983-02-14 Sandoz Ag Sett att framstella stabila losningar av hydrerade mjoldrygealkaloider, deras syntetiska derivat eller deras salter
JPS5487177A (en) * 1977-12-23 1979-07-11 Fujitsu Ltd Component positioning unit
CH642259A5 (de) * 1978-12-21 1984-04-13 Sandoz Ag Galenische zubereitungen fuer orale applikation von ergotalkaloiden.
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen
GB2063670A (en) * 1979-11-28 1981-06-10 Sandoz Products Ltd Ergots and their use in treating minimal brain dysfunction

Also Published As

Publication number Publication date
SE8402199L (sv) 1984-10-23
HK100289A (en) 1989-12-29
CY1499A (en) 1990-08-03
JPH0564124B2 (no) 1993-09-14
DK201884D0 (da) 1984-04-18
IE840977L (en) 1984-10-22
BE899434A (fr) 1984-10-16
GR81973B (no) 1984-12-12
GB8410363D0 (en) 1984-05-31
NL188891C (nl) 1992-11-02
SE8402199D0 (sv) 1984-04-19
HU192050B (en) 1987-05-28
MY100397A (en) 1990-09-17
US4617306A (en) 1986-10-14
CH658992A5 (de) 1986-12-31
PT78455A (en) 1984-05-01
ATA133784A (de) 1991-05-15
IL71601A (en) 1988-12-30
AU571218B2 (en) 1988-04-14
GB2138678A (en) 1984-10-31
AU2712084A (en) 1984-10-25
DK165965B (da) 1993-02-22
SE465751B (sv) 1991-10-28
JPS59205318A (ja) 1984-11-20
AT393625B (de) 1991-11-25
HUT37889A (en) 1986-03-28
DK201884A (da) 1984-10-23
PT78455B (en) 1986-05-27
ZA842993B (en) 1985-11-27
DK165965C (da) 1993-07-26
IE57468B1 (en) 1993-01-27
DD217712A5 (de) 1985-01-23
CA1218932A (en) 1987-03-10
NL8401155A (nl) 1984-11-16
GB2138678B (en) 1986-11-05
IT1199114B (it) 1988-12-30
FR2544614B1 (fr) 1987-08-21
SG53889G (en) 1989-12-08
NZ207917A (en) 1988-05-30
IT8448082A0 (it) 1984-04-20
US4797404A (en) 1989-01-10
IL71601A0 (en) 1984-07-31
PH20922A (en) 1987-06-05
FR2544614A1 (fr) 1984-10-26

Similar Documents

Publication Publication Date Title
RU2221563C2 (ru) Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона
JPS58219117A (ja) 脳不全症の処置方法
JP2007518755A (ja) モノアミン神経伝達物質再取り込み阻害剤及びｎ−メチル−ｄ−アスパラギン酸（ｎｍｄａ）受容体アンタゴニストを含む医薬組成物
WO2007093624A2 (en) Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
CA2123232C (fr) Compositions pharmaceutiques a base d'ebastine ou de ses analogues
FR2896157A1 (fr) Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
KR100209201B1 (ko) 1,4-디히드로피리딘 유도체를 함유하는 고체 분산 정제 및 그의 제조방법
JP2010530888A (ja) アタザナビルを含む錠剤組成物
KR20170061493A (ko) 피마살탄의 신규 염
FR2524314A1 (fr) Medicament a action salidiuretique, contenant des dihydropyridines
US20060030602A1 (en) (S)-amlodipine malate
LU85331A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
CA2333001A1 (en) Benzofuroxan derivatives and their use in treating angina pectoris
EA006772B1 (ru) Прессованная таблетка на основе линезолида и ее применение
LU86289A1 (fr) Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle
MXPA02003452A (es) Tratamiento de combinacion de esclerosis multiple (em), otras condiciones de desmielinacion y neuropatia periferica, especialmente neuropatias dolorosas y neuropatia diabetica.
AU779761B2 (en) Medicament for treatment of neuropathies
EP1682124B1 (fr) Compositions pharmaceutiques a base de sel d'idazoxan ou d´un de ses polymorphes
EP0950050B1 (fr) Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
FR2605222A1 (fr) Agent therapeutique a base de nitrate de n-(2-hydroxyethyl) nicotinamide pour le traitement de troubles associes a l'ischemie cerebrale
JP2022538569A (ja) 睡眠障害を伴うｃｎｓ障害の治療
EP0412877A1 (fr) Nouvelle forme galénique orale améliorant la biodisponibilité
US20200230084A1 (en) Methods of treating disease with dichlorphenamide
JPH05229944A (ja) モノアミノオキシダーゼｂ阻害因子
CH660189A5 (fr) Sels de dioxyde de benzothiazine cristallin et compositions pharmaceutiques les contenant.